太阳集团tyc5997_平台(china)官方网站

细胞程序性死亡蛋白1(PD1)多克隆抗体

Polyclonal Antibody to Programmed Cell Death Protein 1 (PD1)

CD279; PDCD1; SLEB2; HPD1P

  • 细胞程序性死亡蛋白1(PD1)多克隆抗体 产品包装(模拟)
  • 细胞程序性死亡蛋白1(PD1)多克隆抗体 产品包装(模拟)
  • 细胞程序性死亡蛋白1(PD1)多克隆抗体 Used in DAB staining on fromalin fixed paraffin- embedded Kidney tissue
  • PAA751Ra01.jpg Western Blot; Sample: Lane1: Rat Spleen lysate; Lane2: Mouse Spleen lysate; Lane3: Mouse Thymus lysate Primary Ab: 0.2µg/ml Rabbit Anti-Rat PDCD1 Antibody Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对PD1的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别PD1。

用法

Western blotting: 0.2-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号 适用物种：Rattus norvegicus (Rat，大鼠) 应用(仅供研究使用，不用于临床诊断！)
RPA751Ra01 细胞程序性死亡蛋白1(PD1)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA751Ra01 细胞程序性死亡蛋白1(PD1)多克隆抗体 WB; IHC; ICC; IP.

参考文献

杂志 参考文献
Oncotarget Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection. [pubmed:28545019]
CyberLeninka Потенциальные биомаркеры эффективности терапии ниволумабом при метастатическом почечно-клеточном раке [:]
АНАЛИЗ РЕЗУЛЬТАТОВ ЛЕЧЕНИЯ БОЛЬНЫХ МЕТАСТАТИЧЕСКИМ РАКОМ ПОЧКИ, ПОЛУЧАВШИХ АНТИ-PD-1‑ТЕРАПИЮ В РАМКАХ ПРОГРАММЫ … []
International Journal of Molecular Sciences Design and Synthesis of A PD-1 Binding Peptide and Evaluation of Its Anti-Tumor Activity [Pubmed: 30699956]
PLoS One Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated … [Pubmed: 30807610]
Cancers Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study [Pubmed: 32085544]
留言咨询
Baidu
sogou